HealthEquity, Inc. (NASDAQ:HQY) Forecasted to Earn Q1 2026 Earnings of $0.68 Per Share

HealthEquity, Inc. (NASDAQ:HQY) – Research analysts at Zacks Research dropped their Q1 2026 earnings per share estimates for HealthEquity in a research report issued on Monday, September 30th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.68 per share for the quarter, down from their previous estimate of $0.69. The consensus estimate for HealthEquity’s current full-year earnings is $2.25 per share.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%.

A number of other brokerages also recently weighed in on HQY. Robert W. Baird increased their price target on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. KeyCorp increased their price target on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Bank of America lowered their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, September 4th. Finally, JMP Securities reissued a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $103.83.

HealthEquity Stock Down 1.9 %

HealthEquity stock opened at $80.27 on Wednesday. HealthEquity has a 52-week low of $61.81 and a 52-week high of $88.26. The firm has a 50 day moving average price of $76.42 and a two-hundred day moving average price of $79.21. The firm has a market cap of $6.98 billion, a price-to-earnings ratio of 87.25, a PEG ratio of 1.25 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

Insider Transactions at HealthEquity

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares in the company, valued at approximately $7,168,952.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other HealthEquity news, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $81.89, for a total value of $630,962.45. Following the sale, the director now owns 6,070 shares of the company’s stock, valued at $497,072.30. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Rise Advisors LLC purchased a new stake in HealthEquity in the 1st quarter worth approximately $28,000. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the second quarter worth about $35,000. YHB Investment Advisors Inc. bought a new position in HealthEquity during the 1st quarter worth approximately $40,000. Fidelis Capital Partners LLC bought a new stake in HealthEquity in the first quarter valued at approximately $42,000. Finally, Parallel Advisors LLC increased its stake in shares of HealthEquity by 255.5% in the fourth quarter. Parallel Advisors LLC now owns 679 shares of the company’s stock worth $45,000 after buying an additional 488 shares during the period. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.